Cargando…
Long-term methimazole therapy in Graves’ hyperthyroidism and adverse reactions: a Danish multicenter study
PURPOSE: In this prospective multicenter study with patients newly diagnosed with Graves’ hyperthyroidism (GH), we studied the timing and characteristics of adverse drug reactions in patients treated with anti-thyroid drugs (ATD) for up to 48 months. METHODS: Patients with GH were treated with ATD u...
Autores principales: | Karmisholt, J, Andersen, S L, Bulow-Pedersen, I, Krejbjerg, A, Nygaard, B, Carlé, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175582/ https://www.ncbi.nlm.nih.gov/pubmed/35521775 http://dx.doi.org/10.1530/ETJ-22-0031 |
Ejemplares similares
-
Predictors of Initial and Sustained Remission in Patients Treated with Antithyroid Drugs for Graves' Hyperthyroidism: The RISG Study
por: Karmisholt, J., et al.
Publicado: (2019) -
Association between TSH-Receptor Autoimmunity, Hyperthyroidism, Goitre, and Orbitopathy in 208 Patients Included in the Remission Induction and Sustenance in Graves' Disease Study
por: Laurberg, Peter, et al.
Publicado: (2014) -
Hyperthyroidism in pregnancy: design and methodology of a Danish multicenter study
por: Torp, Nanna Maria Uldall, et al.
Publicado: (2023) -
Control of Graves’ hyperthyroidism with very long-term methimazole treatment: a clinical trial
por: Azizi, Fereidoun, et al.
Publicado: (2021) -
Benefits of Long-Term Continuation of Low-Dose Methimazole Therapy in the Prevention of Recurrent Hyperthyroidism in Graves' Hyperthyroid Patients: A Randomized Prospective Controlled Study
por: Lertwattanarak, Raweewan, et al.
Publicado: (2022)